Literature DB >> 20848511

Leukocytoclastic vasculitis: A rare adverse effect secondary to infliximab.

Sami Karoui, Norsaf Bibani, Imed Ben Gorbel, Meriem Serghini, Mouna Mlika, Amel Braham, Ines Chelly, Slim Haouet, Habib Houmène, Azza Filali.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20848511     DOI： 10.1002/ibd.21309

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  4 in total

1.  Allicin alleviates inflammation of trinitrobenzenesulfonic acid-induced rats and suppresses P38 and JNK pathways in Caco-2 cells.

Authors:  Chen Li; Weijian Lun; Xinmei Zhao; Shan Lei; Yandong Guo; Jiayi Ma; Fachao Zhi
Journal:  Mediators Inflamm       Date:  2015-02-02       Impact factor: 4.711

2.  Immediate-type infliximab infusion reaction presenting as purpura.

Authors:  Laura Soong; Bahman Sotoodian; Alain Brassard
Journal:  JAAD Case Rep       Date:  2018-06-20

Review 3.  Vasculitis induced by biological agents used in rheumatology practice: A systematic review.

Authors:  Camila da Silva Cendon Duran; Adriane Souza da Paz; Mittermayer Barreto Santiago
Journal:  Arch Rheumatol       Date:  2021-12-24       Impact factor: 1.007

4.  Anti-TNF-Related Leukocytoclastic Vasculitis in Ulcerative Colitis: A Case Report.

Authors:  Valentina Giorgio; Elisa Blasi; Donato Rigante; Cristina Guerriero; Clara De Simone; Anna Laura Fedele; Giuseppe Stella; Antonio Gasbarrini; Franco Scaldaferri
Journal:  Int J Environ Res Public Health       Date:  2021-06-22       Impact factor: 3.390
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.